Erin Doyle

Title: Erin Doyle: Innovator in Gene Targeting Technologies

Introduction

Erin Doyle is a prominent inventor based in Ames, Iowa. She has made significant contributions to the field of gene targeting, particularly through her innovative work on TAL effector-mediated DNA modification. Her research has implications for various applications in genetic engineering and biotechnology.

Latest Patents

Erin Doyle holds 1 patent related to her work on TAL effector-mediated DNA modification. This patent provides materials and methods for gene targeting, specifically utilizing transcription activator-like effector nucleases, commonly referred to as TALENs. This technology has opened new avenues for precise genetic modifications.

Career Highlights

Throughout her career, Erin has worked with esteemed institutions such as the University of Minnesota and the Iowa State University Research Foundation, Inc. Her experience in these organizations has allowed her to develop and refine her expertise in genetic engineering and biotechnology.

Collaborations

Erin has collaborated with notable scientists in her field, including Daniel F. Voytas and Adam J. Bogdanove. These partnerships have further enhanced her research and contributed to advancements in gene targeting technologies.

Conclusion

Erin Doyle's innovative work in gene targeting exemplifies the impact of her research on biotechnology. Her contributions continue to influence the field and pave the way for future advancements in genetic engineering.